comparemela.com
Home
Live Updates
Injectafer Approved in the U.S. for the Treatment of Iron De
Injectafer Approved in the U.S. for the Treatment of Iron De
Injectafer Approved in the U.S. for the Treatment of Iron Deficiency in Adult Patients with Heart Failure
Injectafer is an intravenous (IV) iron replacement therapy indicated for adult patients with heart failure who have iron deficiency
Related Keywords
United States ,
American ,
Ravi Tayi ,
Drug Administration ,
Luitpold Pharmaceuticals Inc ,
Pharmacosmos Therapeutics Inc ,
American Regent Inc ,
York Heart Association Functional Classification ,
American Heart Association ,
European Union ,
Daiichi Sankyo Inc ,
Pharmaceuticals Inc ,
Daiichi Sankyo Group ,
York Heart Association ,
Allergan ,
Daiichi Sankyo ,
American Regent ,
New York Heart Association ,
Chief Medical Officer ,
Stroke Statistics ,
Card Fail ,
Iron Deficiency ,
Heart Failure ,
Current Concepts ,
Heart Failure Demand Assessment ,
Outpatient Setting Working Meeting ,
Basking Ridge ,
American Heart ,
Eur Heart ,
Integrated Summary ,
Periodic Safety Update Report ,
Vifor Pharma Annual ,